Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ParvOryx in metastatic pancreatic cancer
NCT02653313Phase 2Completed
- Start
- Dec 2015
- Primary completion
- May 2018
- Countries
- 1
01
Overview
A Phase 2 trial of ParvOryx in pancreatic ductal adenocarcinoma (PDAC). Started Dec 2015; status: completed.
02
Drugs
ParvOryx
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02653313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02653313.